Cannabis producers in Australia avoid ‘unimportant’ designations | Instant News


The Australian Government has identified certain “non-essential” industries to implement limited operations to combat the new coronavirus pandemic – and medical marijuana is not on the list.

That means medical cannabis producers and their supply chains can continue to operate as far as the federal government is concerned.

“Business in the cannabis drug industry is not on that list,” a health department spokesman confirmed Marijuana Business Daily in email.

However, state and territory governments have announced separate local restrictions for businesses operating in their respective jurisdictions.

The Australian Cannabis Industry Drug Industry group says medical cannabis qualifies as important service under public health orders issued by states and territories.

“The MCIA has consulted with the government and has confirmed that the cannabis drug sector is covered by existing public health orders issued by states and territories, outlining that it will work – where working remotely is not an option – and get medical care or supplies. is an important service that is excluded from social restrictions, “said Rosemary Richards, executive manager.

“Our sector complies with both of these requirements.”

Australia recently reported months of patient approval for medical marijuana.

Administration of Therapeutic Goods approved almost 4,000 Application for Special Access Scheme Category B (SAS B) in March.

That makes the total for this year 12,662 – already 53% of the 2019 agreement.

Most medical cannabis prescriptions in Australia are under SAS B.

Regulators hope the number of recipes will rise at least 70,000 by 2020.

For more than Marijuana Business Daily ongoing coronavirus pandemic coverage and its impact on the cannabis industry, Click here.

image source


Please enter your comment!
Please enter your name here